相关实验视频
Updated: Jun 4, 2025

05:21
Establishment of A Mouse Model of Aqueous Deficiency Dry Eye
Published on: November 1, 2024
459
咖啡因在干眼疾病和梅博米腺功能障碍中的保护作用:从临床和实验模型的见解
Yu-Zhi Li1, Chao Wang1, Xi Peng1
1Department of Ophthalmology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
International immunopharmacology
|December 22, 2024
概括
摄入咖啡因可以通过减少炎症和亡来保护眼睛表面,为干眼病 (DED) 和梅博米腺功能障碍 (MGD) 提供潜在的新疗法.
科学领域:
- 眼科医生 眼科 眼科
- 细胞生物学 细胞生物学
- 免疫学 免疫学 免疫学
背景情况:
- 干眼病 (DED) 和梅博米腺功能障碍 (MGD) 与眼睛表面炎症和细胞死亡有关.
- 目前对DED和MGD的治疗有局限性.
研究的目的:
- 为了研究咖啡因在眼睛表面的治疗潜力.
- 在DED和MGD模型中检查咖啡因对眼炎性细胞因子,炎症和亡的影响.
主要方法:
- 临床研究比较接受咖啡因与对照组的参与者.
- 在实验室实验中,使用与咖啡因和脂多糖 (LPS) 治疗的老鼠梅博米腺上皮细胞 (RMGEC) 和人类角膜上皮细胞 (HCEC).
- 在体内研究使用非脂蛋白E淘汰赛 (ApoE-/-) 食含咖啡因饮食的小鼠.
主要成果:
- 咖啡因消费导致了更健康的眼睛表面,减少了眼炎性细胞因子,并在临床参与者中降低了DED流行率.
- 在体外研究表明,咖啡因减弱的炎症和LPS刺激的RMGECs和HCECs中的亡.
- 在体内研究表明,美博米腺和角膜形态得到改善,咖啡因养小鼠的炎症和亡减少. 咖啡因失活的核因子卡帕B (NF-κB) 酸化.
结论:
- 咖啡因在眼睛表面表现出保护作用.
- 咖啡因为管理DED和MGD提供了一种新的治疗途径.
相关概念视频
Direct-Acting Cholinergic Agonists: Therapeutic Uses
683
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
683
Accessory Structures of the Eye
1.5K
Optical perception, or vision, is an extraordinary sense dependent on converting light signals received via the ocular organs. These organs, known as eyes, are securely positioned within the bony cavities of the skull, called orbits. The orbits serve a dual purpose: a protective shield for the ocular globes and a stable attachment point for the soft ocular tissues. The eye's external protective mechanisms include the eyelids, which are edged with lashes that act as a barrier against foreign...
1.5K
Open Angle Glaucoma: Treatment
391
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
391
Direct-Acting Cholinergic Agonists: Pharmacological Actions
1.2K
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
1.2K
Direct-Acting Cholinergic Agonists: Pharmacokinetics
1.0K
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
1.0K
Cholinergic Antagonists: Pharmacological Actions
901
Antimuscarinic drugs block muscarinic receptors in multiple systems, including the gut, eye, smooth muscles, respiratory tract, cardiovascular, and central nervous systems. They produce similar effects with varying selectivity depending on the specific agent and tissue. Here are the key pharmacological actions of antimuscarinics:
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
901

